Biography
Cao Longxiang, a prominent figure in the Chinese pharmaceutical industry, chairs Hubei Jumpcan Pharmaceutical, one of China's largest drug companies. With a net worth estimated at $2.8 billion as of February 2, 2026, he has built a substantial fortune through his leadership in the healthcare sector. His career began with a role as a manager at a cement factory before transitioning into the pharmaceutical business. He now owns more than 60% of Hubei Jumpcan Pharmaceutical. His son, Cao Fei, serves as the company's vice chairman.